Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis (PsA) Treatment Market Growth (Status and Outlook) 2019-2024

Request for Sample of this report
Buy now

Table of Contents

    2019-2024 Global Psoriatic Arthritis (PsA) Treatment Market Report (Status and Outlook)

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size 2014-2024
        • 2.1.2 Psoriatic Arthritis (PsA) Treatment Market Size CAGR by Region
      • 2.2 Psoriatic Arthritis (PsA) Treatment Segment by Type
        • 2.2.1 Nonsteriodal Anti-inflammatory Drugs
        • 2.2.2 Disease Modifying Antirheumatic Drugs
        • 2.2.3 Biologics
      • 2.3 Psoriatic Arthritis (PsA) Treatment Market Size by Type
        • 2.3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Type (2014-2019)
        • 2.3.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Type (2014-2019)
      • 2.4 Psoriatic Arthritis (PsA) Treatment Segment by Application
        • 2.4.1 Hospitals
        • 2.4.2 Clinics
        • 2.4.3 Others
      • 2.5 Psoriatic Arthritis (PsA) Treatment Market Size by Application
        • 2.5.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Application (2014-2019)
        • 2.5.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Growth Rate by Application (2014-2019)

      3 Global Psoriatic Arthritis (PsA) Treatment by Players

      • 3.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players
        • 3.1.1 Global Psoriatic Arthritis (PsA) Treatment Market Size by Players (2017-2019)
        • 3.1.2 Global Psoriatic Arthritis (PsA) Treatment Market Size Market Share by Players (2017-2019)
      • 3.2 Global Psoriatic Arthritis (PsA) Treatment Key Players Head office and Products Offered
      • 3.3 Market Concentration Rate Analysis
        • 3.3.1 Competition Landscape Analysis
        • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.4 New Products and Potential Entrants
      • 3.5 Mergers & Acquisitions, Expansion

      4 Psoriatic Arthritis (PsA) Treatment by Regions

      • 4.1 Psoriatic Arthritis (PsA) Treatment Market Size by Regions
      • 4.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size Growth
      • 4.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size Growth
      • 4.4 Europe Psoriatic Arthritis (PsA) Treatment Market Size Growth
      • 4.5 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size Growth

      5 Americas

      • 5.1 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Countries
      • 5.2 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Type
      • 5.3 Americas Psoriatic Arthritis (PsA) Treatment Market Size by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Countries
      • 6.2 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Type
      • 6.3 APAC Psoriatic Arthritis (PsA) Treatment Market Size by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Psoriatic Arthritis (PsA) Treatment by Countries
      • 7.2 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Type
      • 7.3 Europe Psoriatic Arthritis (PsA) Treatment Market Size by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Psoriatic Arthritis (PsA) Treatment by Countries
      • 8.2 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Type
      • 8.3 Middle East & Africa Psoriatic Arthritis (PsA) Treatment Market Size by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Global Psoriatic Arthritis (PsA) Treatment Market Forecast

      • 10.1 Global Psoriatic Arthritis (PsA) Treatment Market Size Forecast (2019-2024)
      • 10.2 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions
        • 10.2.1 Global Psoriatic Arthritis (PsA) Treatment Forecast by Regions (2019-2024)
        • 10.2.2 Americas Market Forecast
        • 10.2.3 APAC Market Forecast
        • 10.2.4 Europe Market Forecast
        • 10.2.5 Middle East & Africa Market Forecast
      • 10.3 Americas Forecast by Countries
        • 10.3.1 United States Market Forecast
        • 10.3.2 Canada Market Forecast
        • 10.3.3 Mexico Market Forecast
        • 10.3.4 Brazil Market Forecast
      • 10.4 APAC Forecast by Countries
        • 10.4.1 China Market Forecast
        • 10.4.2 Japan Market Forecast
        • 10.4.3 Korea Market Forecast
        • 10.4.4 Southeast Asia Market Forecast
        • 10.4.5 India Market Forecast
        • 10.4.6 Australia Market Forecast
      • 10.5 Europe Forecast by Countries
        • 10.5.1 Germany Market Forecast
        • 10.5.2 France Market Forecast
        • 10.5.3 UK Market Forecast
        • 10.5.4 Italy Market Forecast
        • 10.5.5 Russia Market Forecast
        • 10.5.6 Spain Market Forecast
      • 10.6 Middle East & Africa Forecast by Countries
        • 10.6.1 Egypt Market Forecast
        • 10.6.2 South Africa Market Forecast
        • 10.6.3 Israel Market Forecast
        • 10.6.4 Turkey Market Forecast
        • 10.6.5 GCC Countries Market Forecast
      • 10.7 Global Psoriatic Arthritis (PsA) Treatment Forecast by Type
      • 10.8 Global Psoriatic Arthritis (PsA) Treatment Forecast by Application

      11 Key Players Analysis

      • 11.1 Pfizer
        • 11.1.1 Company Details
        • 11.1.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.1.3 Pfizer Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.1.4 Main Business Overview
        • 11.1.5 Pfizer News
      • 11.2 Johnson & Johnson
        • 11.2.1 Company Details
        • 11.2.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.2.3 Johnson & Johnson Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.2.4 Main Business Overview
        • 11.2.5 Johnson & Johnson News
      • 11.3 AbbVie
        • 11.3.1 Company Details
        • 11.3.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.3.3 AbbVie Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.3.4 Main Business Overview
        • 11.3.5 AbbVie News
      • 11.4 Novartis
        • 11.4.1 Company Details
        • 11.4.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.4.3 Novartis Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.4.4 Main Business Overview
        • 11.4.5 Novartis News
      • 11.5 UCB
        • 11.5.1 Company Details
        • 11.5.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.5.3 UCB Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.5.4 Main Business Overview
        • 11.5.5 UCB News
      • 11.6 Roche
        • 11.6.1 Company Details
        • 11.6.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.6.3 Roche Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.6.4 Main Business Overview
        • 11.6.5 Roche News
      • 11.7 Bristol-Myers Squibb
        • 11.7.1 Company Details
        • 11.7.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.7.3 Bristol-Myers Squibb Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.7.4 Main Business Overview
        • 11.7.5 Bristol-Myers Squibb News
      • 11.8 Eli Lilly
        • 11.8.1 Company Details
        • 11.8.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.8.3 Eli Lilly Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.8.4 Main Business Overview
        • 11.8.5 Eli Lilly News
      • 11.9 Amgen
        • 11.9.1 Company Details
        • 11.9.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.9.3 Amgen Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.9.4 Main Business Overview
        • 11.9.5 Amgen News
      • 11.10 AstraZeneca
        • 11.10.1 Company Details
        • 11.10.2 Psoriatic Arthritis (PsA) Treatment Product Offered
        • 11.10.3 AstraZeneca Psoriatic Arthritis (PsA) Treatment Revenue, Gross Margin and Market Share (2017-2019)
        • 11.10.4 Main Business Overview
        • 11.10.5 AstraZeneca News
      • 11.11 Celgene

      12 Research Findings and Conclusion

      According to this study, over the next five years the Psoriatic Arthritis (PsA) Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Psoriatic Arthritis (PsA) Treatment business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares and growth opportunities of Psoriatic Arthritis (PsA) Treatment market by product type, application, key companies and key regions.

      This study considers the Psoriatic Arthritis (PsA) Treatment value generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
      Nonsteriodal Anti-inflammatory Drugs
      Disease Modifying Antirheumatic Drugs
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
      Hospitals
      Clinics
      Others

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Pfizer
      Johnson & Johnson
      AbbVie
      Novartis
      UCB
      Roche
      Bristol-Myers Squibb
      Eli Lilly
      Amgen
      AstraZeneca
      Celgene

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Psoriatic Arthritis (PsA) Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Psoriatic Arthritis (PsA) Treatment market by identifying its various subsegments.
      Focuses on the key global Psoriatic Arthritis (PsA) Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Psoriatic Arthritis (PsA) Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the size of Psoriatic Arthritis (PsA) Treatment submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      Buy now